CLASS II ONGOING Device recall · Reported 10 Sep 2025 · FDA Enforcement Report

Platelia Toxo IgM recalled by Bio-Rad Laboratories

Bio-Rad Laboratories is recalling Platelia Toxo IgM, distributed nationwide in the US. The recall was initiated on 30 May 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCatalog Number: 26211 UDI-DI code: 03610520005552 Batch/Lot Number: 4L0054
Quantity recalled35 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2515-2025
FDA event ID
97106
Recalling firm
Bio-Rad Laboratories, Woodinville, WA
Classification
Class II
Status
Ongoing
Recall initiated
30 May 2025
FDA classified
4 Sep 2025
Reported
10 Sep 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

30 May 2025Recall initiated by company
4 Sep 2025Classified by FDA+97 days
10 Sep 2025Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to a risk of false positive results that could lead to unnecessary medical treatment.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Platelia Toxo IgM Catalog Number 26211 UDI Code: 03610520005552 The Platelia Toxo IgM assay is a semi-quantitative immunocapture enzyme immunoassay kit for the detection of IgM antibodies to Toxoplasma gondii in human serum, plasma or cord blood specimens.

Where it was distributed

U.S. Nationwide distribution in the states of CA, CO, FL, NC and NV.

Nationwide CaliforniaColoradoFloridaNorth CarolinaNevada

Questions about this recall

Why was it recalled?

Due to a risk of false positive results that could lead to unnecessary medical treatment.

Which lots are affected?

Catalog Number: 26211 UDI-DI code: 03610520005552 Batch/Lot Number: 4L0054

Where was it sold?

U.S. Nationwide distribution in the states of CA, CO, FL, NC and NV.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Bio-Rad Laboratories

All 27

Other Test Kits & Diagnostics recalls

All 2,661